Onconova Therapeutics, Inc.

NASDAQ:ONTX

0.9953 (USD) • At close April 2, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011
Assets:
Current Assets:
Cash & Cash Equivalents 20.82138.75755.0719.02522.72616.974.02421.419.79943.58260.00981.5272.713
Short Term Investments 000000000039.99400
Cash and Short Term Investments 20.82138.75755.0719.02522.72616.974.02421.419.79943.582100.00381.5272.713
Net Receivables 0.0180.0290.0280.0370.0980.0350.0590.0311.5040000.478
Inventory 1.420.0970.0290.090.025001.5651.6870000
Other Current Assets 0.4010.5610.3320.7220.650.760.820.0730.1950.3874.3871.7250.627
Total Current Assets 22.6639.34755.4319.78423.47417.7654.90323.06923.18546.905104.3983.2523.818
Non-Current Assets:
Property, Plant & Equipment, Net 0.0220.0240.0380.0520.050.0090.0640.1520.2480.420.6260.4630.507
Goodwill 0000000000000
Intangible Assets 0000000000000
Goodwill and Intangible Assets 0000000000000
Long Term Investments 0000000000000
Tax Assets 0000000000000
Other Non-Current Assets 0.0010.0010.010.150.150.1490.0120.0120.0120.0120.1370.1370.137
Total Non-Current Assets 0.0230.0250.0480.2020.20.1580.0760.1640.260.4320.7630.60.644
Total Assets 22.68339.37255.47819.98623.67417.9234.97923.23323.44547.337105.15383.8524.462
Liabilities & Equity:
Current Liabilities:
Account Payables 5.6193.862.7574.8334.2714.0396.1865.3233.4214.0273.715.5175.614
Short Term Debt -3,374,996.62500004.1604.1843.7235.7725.4363.7681.982
Tax Payables 0000000000.0180.30200
Deferred Revenue 0.2260.2260.2260.2260.2260.2260.4550.4550.4550.4550.7883.9070.455
Other Current Liabilities 3,375,0003.963.1324.9623.7950.0133.3350.1980.0060.0050.40412.1864.03
Total Current Liabilities 9.228.0466.11510.0218.2928.4389.97610.167.60510.25910.33825.37812.081
Non-Current Liabilities:
Long Term Debt 0000000000000
Deferred Revenue Non-Current 2.7913.0173.2433.4693.6953.9224.0914.545513.45513.90915.42110.718
Deferred Tax Liabilities Non-Current 0000000000000
Other Non-Current Liabilities 0000.3210.1130.1761.7733.40100.0010.0060.044120.082
Total Non-Current Liabilities 2.7913.0173.2433.793.8084.0985.8647.946513.45613.91515.465130.8
Total Liabilities 12.01111.0639.35813.81112.112.53615.8418.10612.60523.71524.25340.843142.881
Equity:
Preferred Stock 0000000000105.15300
Common Stock 0.210.2090.2091.8591.1120.0570.1080.0680.2550.2170.2150.1540.022
Retained Earnings -482.631-463.683-444.719-428.556-403.399-381.896-362.316-338.224-318.557-294.578-230.896-168.353-138.441
Accumulated Other Comprehensive Income/Loss -0.023-0.033-0.0140.014-0.018-0.0120.003-0.031-0.022-0.0130.001-1.348-1.131
Other Total Stockholders Equity 493.116491.816490.644432.858413.879387.238352.681344.529330.292319.314205.94212.5561.131
Total Shareholders Equity 10.67228.30946.126.17511.5745.387-11.6914.29710.0122.74880.41343.009-138.419
Total Equity 10.67228.30946.126.17511.5745.387-11.6914.29710.0122.74880.41343.009-138.419
Total Liabilities & Shareholders Equity 22.68339.37255.47819.98623.67417.9234.97923.23323.44547.337105.15383.8524.462